A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer. The drug, called daraxonrasib, appears to be a breakthrough in managing a disease that has…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.